Ganga Pharmaceuticals Ltd is in the business of manufacturing & trading in Ayurvedic pharmaceuticals & allied productsBusiness Overview: Company does production of Ayurvedic Medicines by using techniques strictly as per Ancient text and Ayurved pharma companies. Apart from manufacturing, it is also into marketing and distribution of Bulk Ayurvedic Medicines...
Ganga Pharmaceuticals has updated shareholders on accessing its Annual Report for 2025-26 and the Notice for the upcoming 37th Annual General Meeting (AGM). For those without registered email addresses, a web link has been provided. The AGM is set for Saturday, September 26, 2026, at 4:30 p.m. at the company's...
Ganga Pharmaceuticals' Registrar and Share Transfer Agent, KFIN Technologies, has confirmed timely submission of data on dematerialized and rematerialized shares for the quarter ending June 30, 2026. This process is crucial for maintaining accurate shareholder records and ensures the company's compliance with investor-related regulatory requirements. It indicates smooth operational handling...
Trescon Limited has initiated a postal ballot to seek shareholder approval on several key matters. These include affirming significant related party transactions and authorizing remuneration for Mr. Dinesh Patel, the Managing Director, and Mr. Kishore Patel, a Whole-time Director, for the financial years 2026-2027 and 2027-2028. Shareholders can cast their...
Ganga Pharmaceuticals Limited has informed stakeholders that it is exempt from submitting the Annual Secretarial Compliance Report for the financial year ended March 31, 2026. This exemption applies because the company qualifies as a Listed SME. This update clarifies its compliance status, indicating that certain regulatory reporting requirements are not...
I need access to the document containing the company's announcement or update to generate the summary according to your preferences. Please provide the document.
